红细胞在临床相关出血倾向与并发症中的作用
本文综述红细胞在止血与血栓形成中的多重作用,包括释放血小板激动剂、促进剪切力诱导的血管性血友病因子展开、促凝血能力及结合纤维蛋白等。基线贫血在使用抗凝和/或抗血栓药物时使出血并发症和死亡风险加倍。患者血液管理指南支持减少输血,但未涉及严重遗传性和获得性出血性疾病。
要点
- 红细胞与血小板共同启动止血并稳定纤维蛋白和血凝块结构。
- 基线贫血在使用抗凝和/或抗血栓药物时使出血并发症和死亡风险加倍。
- 患者血液管理指南支持减少输血,但未涉及严重遗传性和获得性出血性疾病。
核心结论
- 红细胞在止血和血栓形成中具有多种功能,包括释放血小板激动剂、促进剪切力诱导的血管性血友病因子展开、促凝血能力和结合纤维蛋白。
- 基线贫血在使用抗凝和/或抗血栓药物时使出血并发症和死亡风险加倍。
- 患者血液管理指南支持减少输血,但未涉及严重遗传性和获得性出血性疾病,未来需要相关指导。
研究设计与样本
- 综述,总结红细胞在血小板黏附、聚集、凝血酶生成和纤维蛋白形成各步骤中的临床相关特性和概况。
主要发现
- 红细胞释放血小板激动剂、促进剪切力诱导的血管性血友病因子展开、具有促凝血能力并可与纤维蛋白结合。
- 血凝块收缩将红细胞压缩成紧密排列的多面体细胞阵列,形成不透水的止血密封。
- 基线贫血在使用抗凝和/或抗血栓药物时使出血并发症和死亡风险加倍。
- 贫血是复发性胃肠道和泌尿生殖道出血、妊娠和分娩并发症的危险因素。
临床怎么用
- 患者血液管理指南支持减少输血,但该策略未涉及严重遗传性和获得性出血性疾病,未来需要相关指导。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The multiple roles of red blood cells (RBCs) are often neglected as contributors in hemostasis and thrombosis. Proactive opportunities to increase RBC numbers, either acutely or subacutely in the case of iron deficiency, are critical as RBCs are the cellular elements that initiate hemostasis together with platelets and stabilize fibrin and clot structure. RBCs also possess several functional properties to assist hemostasis: releasing platelet agonists, promoting shear force-induced von Willebrand factor unfolding, procoagulant capacity, and binding to fibrin. Additionally, blood clot contraction is important to compress RBCs to form a tightly packed array of polyhedrocytes, making an impermeable seal for hemostasis. All these functions are important for patients having intrinsically poor capacity to cease bleeds (ie, hemostatic disorders) but, conversely, can also play a role in thrombosis if these RBC-mediated reactions overshoot. One acquired example of bleeding with anemia is in patients treated with anticoagulants and/or antithrombotic medication because upon initiation of these drugs, baseline anemia doubles the risk of bleeding complications and mortality. Also, anemia is a risk factor for reoccurring gastrointestinal and urogenital bleeds, pregnancy, and delivery complications. This review summarizes the clinically relevant properties and profiles of RBCs at various steps of platelet adhesion, aggregation, thrombin generation, and fibrin formation, including both structural and functional elements. Regarding patient blood management guidelines, they support minimizing transfusions, but this approach does not deal with severe inherited and acquired bleeding disorders where a poor hemostatic propensity is exacerbated by limited RBC availability, for which future guidance will be needed.
引用
- Lassila R, Weisel JW. Role of red blood cells in clinically relevant bleeding tendencies and complications. J Thromb Haemost. 2023. PMID: 37210074. doi:10.1016/j.jtha.2023.05.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。